» Authors » Bismarck Odei

Bismarck Odei

Explore the profile of Bismarck Odei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 82
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalathoor S, Ghazi S, Otieno B, Babcook M, Chen S, Nidhi N, et al.
Int J Cancer . 2024 Aug; 155(11):1958-1968. PMID: 39155749
Contemporary anticancer therapies frequently have different efficacy and side effects in men and women. Yet, whether women are well-represented in pivotal trials supporting contemporary anticancer drugs is unknown. Leveraging the...
2.
Hutten R, Odei B, Johnson S, Tward J
JCO Precis Oncol . 2024 Feb; 8:e2300364. PMID: 38330260
Purpose: We aim to independently validate the prognostic utility of the combined cell-cycle risk (CCR) multimodality threshold to estimate risk of early metastasis after definitive treatment of prostate cancer and...
3.
Hutten R, Odei B, Rivera A, Suneja G
Int J Radiat Oncol Biol Phys . 2022 Sep; 114(2):195-197. PMID: 36055318
No abstract available.
4.
Odei B, Kahn J, Holliday E, Diaz D, Bello-Pardo E, Odei J, et al.
Adv Radiat Oncol . 2021 Jul; 6(5):100735. PMID: 34278054
Purpose: We aimed to evaluate the growth of women within the general radiation oncology (RO) workforce in comparison to the growth among other medical specialties. We also sought to create...
5.
Odei B, Das P, Pinnix C, Raval R, Holliday E
Adv Radiat Oncol . 2021 Jan; 6(1):100524. PMID: 33490722
No abstract available.
6.
Odei B, Bae S, Diaz D
Radiother Oncol . 2020 Sep; 154:123-124. PMID: 32976872
No abstract available.
7.
Odei B, Holliday E, Jagsi R, Chino F, Schulmire C, Kudrimoti M, et al.
Int J Radiat Oncol Biol Phys . 2020 Aug; 109(2):637-638. PMID: 32798607
No abstract available.
8.
Odei B, Boothe D, Frandsen J, Poppe M, Gaffney D
Clin Lymphoma Myeloma Leuk . 2017 Oct; 17(12):819-824. PMID: 29051078
Background: The goal of this study was to assess the survival differences seen in early-stage and advanced-stage nodular lymphocytic predominant Hodgkin lymphoma (NLPHL) based on treatment modality. Patients And Methods:...
9.
Odei B, Rwigema J, Eilber F, Eilber F, Selch M, Singh A, et al.
Am J Clin Oncol . 2017 Jun; 41(9):827-831. PMID: 28640064
Objectives: Myxofibrosarcoma (MFS) is reported to have a higher risk of local recurrence (LR) following definitive surgical excision relative to other soft tissue sarcomas. We reviewed our clinical experience treating...
10.
Boothe D, Williams N, Odei B, Poppe M, Werner T, Suneja G, et al.
Int J Gynecol Cancer . 2017 May; 27(5):912-922. PMID: 28498257
Objective: Early-stage high-risk endometrial cancer (HREC) treated with adjuvant radiotherapy (aRT) alone has been associated with an increased risk of distant relapse. The addition of chemotherapy to radiotherapy (aCRT) may...